董事介绍
注:董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Gail K. Boudreaux | 女 | President and Chief Executive Officer,Director | 61 | 1934.82万美元 | 8.02 | 2022-04-01 |
| Antonio F. Neri | 男 | Director | 54 | 32.00万美元 | 0.30 | 2022-04-01 |
| Bahija Jallal | 女 | Director | 60 | 34.19万美元 | 0.29 | 2022-04-01 |
| Susan D. DeVore | -- | Director | 63 | 未披露 | 未持股 | 2022-04-01 |
| Elizabeth E. Tallett | 女 | Independent Chair Of The Board | 72 | 57.00万美元 | 0.90 | 2022-04-01 |
| R. Kerry Clark | 男 | Director | 69 | 35.00万美元 | 0.78 | 2022-04-01 |
| Lewis Hay, III | 男 | Director | 66 | 35.47万美元 | 0.96 | 2022-04-01 |
| Ryan M. Schneider | 男 | Director | 52 | 32.00万美元 | 0.47 | 2022-04-01 |
| Ramiro G. Peru | 男 | Director | 66 | 36.06万美元 | 1.00 | 2022-04-01 |
| Robert L. Dixon, Jr. | 男 | Director | 66 | 35.06万美元 | 0.95 | 2022-04-01 |
| Susan D. DeVore | 女 | Director | 63 | 20.54万美元 | 0.04 | 2022-04-01 |
高管介绍
注:高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Gail K. Boudreaux | 女 | President and Chief Executive Officer,Director | 61 | 1934.82万美元 | 8.02 | 2022-04-01 |
| Peter D. Haytaian | 男 | Executive Vice President and President, Diversified Business Group and IngenioRx | 52 | 788.89万美元 | 0.78 | 2022-04-01 |
| Ronald W. Penczek | 男 | Chief Accounting Officer and Controller | 57 | 未披露 | 未持股 | 2022-04-01 |
| Felicia F. Norwood | 女 | Executive Vice President and President, Government Business Division | 62 | 583.39万美元 | 1.38 | 2022-04-01 |
| Charles M. Kendrick, Jr. | 男 | Executive Vice President and President, Commercial and Specialty Business Division | 56 | 未披露 | 未持股 | 2022-04-01 |
| Blair W. Todt | 男 | Executive Vice President and Chief Legal Officer | 54 | 未披露 | 未持股 | 2022-04-01 |
| John E. Gallina | 男 | Executive Vice President and Chief Financial Officer | 62 | 614.13万美元 | 4.51 | 2022-04-01 |
| Gloria M. McCarthy | 女 | Executive Vice President and Chief Administrative Officer | 69 | 592.31万美元 | 4.99 | 2022-04-01 |
董事简历
中英对照 |  中文 |  英文- Gail K. Boudreaux
-
Gail K. Boudreaux,自2011年1月担任联合健康集团的首席执行官;自2008年5月起担任联合健康集团的执行副总裁;从2005年至2008年,她担任医疗保健服务公司“HCSC”的外部运营执行副总裁;此前担任伊利诺伊州蓝十字公司和蓝盾公司的总裁,医疗保健服务公司的一个部门。加入HCSC前,包德留克斯女士在安泰公司担任多个职位,包括安泰保险集团高级副总裁。包德留克斯女士获得了哥伦比亚商学院的工商管理硕士学位和达特茅斯学院的心理学学士学位。她担任埃克西尔能源公司的董事,此前担任健赞公司的董事。
Gail K. Boudreaux has served as the President & Chief Executive Officer of Anthem, Inc., a leading health benefits provider, since November 2017. From July 2015 to November 2017 Ms. Boudreaux served as Chief Executive Officer of GKB Global Health, LLC, a healthcare consulting company. She previously held executive level leadership positions at UnitedHealth Group, Inc. and its subsidiary, UnitedHealthcare, and at Health Care Services Corporation and Aetna, Inc..Anthem, Inc.,Zimmer Biomet Holdings, Inc.,Xcel Energy Inc.,Novavax, Inc.. - Gail K. Boudreaux,自2011年1月担任联合健康集团的首席执行官;自2008年5月起担任联合健康集团的执行副总裁;从2005年至2008年,她担任医疗保健服务公司“HCSC”的外部运营执行副总裁;此前担任伊利诺伊州蓝十字公司和蓝盾公司的总裁,医疗保健服务公司的一个部门。加入HCSC前,包德留克斯女士在安泰公司担任多个职位,包括安泰保险集团高级副总裁。包德留克斯女士获得了哥伦比亚商学院的工商管理硕士学位和达特茅斯学院的心理学学士学位。她担任埃克西尔能源公司的董事,此前担任健赞公司的董事。
- Gail K. Boudreaux has served as the President & Chief Executive Officer of Anthem, Inc., a leading health benefits provider, since November 2017. From July 2015 to November 2017 Ms. Boudreaux served as Chief Executive Officer of GKB Global Health, LLC, a healthcare consulting company. She previously held executive level leadership positions at UnitedHealth Group, Inc. and its subsidiary, UnitedHealthcare, and at Health Care Services Corporation and Aetna, Inc..Anthem, Inc.,Zimmer Biomet Holdings, Inc.,Xcel Energy Inc.,Novavax, Inc..
- Antonio F. Neri
-
Antonio F. Neri自2017年12月以来一直担任公司董事。Neri先生自2018年以来一直担任惠普企业公司“ Hewlett Packard Enterprise”技术公司的总裁兼首席执行官。在惠普公司,他还担任过 2017年至2018年担任总裁,2015年至2017年担任企业集团执行副总裁兼总经理。在惠普公司从惠普公司(技术公司)分离出来之前,内里先生自1995年以来一直在惠普公司担任各种领导职务。 包括2014年至2015年企业集团高级副总裁兼总经理,2013年至2014年HP服务器高级副总裁兼总经理,以及2011年至2013年HP技术服务高级副总裁兼总经理。Neri先生曾担任 自2018年起担任惠普企业总监。2016年至2017年,他担任H3C Technologies Co.,LTD(信息技术公司)董事。
Antonio F. Neri Hewlett Packard Enterprise Company "Hewlett Packard Enterprise”, a technology company, President and CEO (since 2018), President (2017-2018) and Executive Vice President and General Manager, Enterprise Group (2015-2017), HP Inc., a technology company, various positions (1995-2015) including Senior Vice President and General Manager, Enterprise Group (2014-2015), Senior Vice President and General Manager, HP Networking Business Units -2014 Senior Vice President and General Manager, HP Servers (2013-2014) and Senior Vice President and General Manager, HP Technology Services (2011-2013), Hewlett Packard Enterprise, Director (since 2018),H3C Technologies Co., LTD, an information technology company, Director (2016-2017). - Antonio F. Neri自2017年12月以来一直担任公司董事。Neri先生自2018年以来一直担任惠普企业公司“ Hewlett Packard Enterprise”技术公司的总裁兼首席执行官。在惠普公司,他还担任过 2017年至2018年担任总裁,2015年至2017年担任企业集团执行副总裁兼总经理。在惠普公司从惠普公司(技术公司)分离出来之前,内里先生自1995年以来一直在惠普公司担任各种领导职务。 包括2014年至2015年企业集团高级副总裁兼总经理,2013年至2014年HP服务器高级副总裁兼总经理,以及2011年至2013年HP技术服务高级副总裁兼总经理。Neri先生曾担任 自2018年起担任惠普企业总监。2016年至2017年,他担任H3C Technologies Co.,LTD(信息技术公司)董事。
- Antonio F. Neri Hewlett Packard Enterprise Company "Hewlett Packard Enterprise”, a technology company, President and CEO (since 2018), President (2017-2018) and Executive Vice President and General Manager, Enterprise Group (2015-2017), HP Inc., a technology company, various positions (1995-2015) including Senior Vice President and General Manager, Enterprise Group (2014-2015), Senior Vice President and General Manager, HP Networking Business Units -2014 Senior Vice President and General Manager, HP Servers (2013-2014) and Senior Vice President and General Manager, HP Technology Services (2011-2013), Hewlett Packard Enterprise, Director (since 2018),H3C Technologies Co., LTD, an information technology company, Director (2016-2017).
- Bahija Jallal
-
Bahija Jallal自2018年2月起担任公司董事。Jallal女士自2019年1月起担任Immunocore Limited T细胞受体生物技术公司首席执行官。在此之前,她曾担任AstraZeneca PLC“ AstraZeneca”执行副总裁。 ”(制药和生物制药业务)和阿斯利康(AstraZeneca)的子公司MedImmune(生物技术业务)总裁,自2013年起。她于2006年加入MedImmune,并于2010年至2013年担任各种研发职位,包括研发执行副总裁。在加入AstraZeneca之前,Jallal曾在Chiron公司工作,担任副总裁,药物评估和开发。Bahija在巴黎第七大学获得生物学硕士学位,在巴黎第六大学皮埃尔和玛丽居里大学获得生理学博士学位。Jallal女士自2019年1月起担任Immunocore Limited董事,自2019年4月起担任Guardant Health,Inc。(精密肿瘤学公司)董事。她是约翰·霍普金斯大学董事会成员,也是约翰·霍普金斯大学董事会成员。马里兰州健康科学研究园公司。贾拉勒女士还曾于2016年至2018年担任科学界妇女协会的董事和前任主席。
Bahija Jallal Immunocore Limited, a T-cell receptor biotechnology company, CEO since January 2019.AstraZeneca PLC ("AstraZeneca”), a pharmaceutical and biopharmaceutical business, Executive Vice President (2013-2019).MedImmune, a biotechnology business and a subsidiary of AstraZeneca, President (2013-2019), Executive Vice President, Research and Development (2010-2013) and various other research and development positions (2006-2010).Immunocore Limited, Director (since 2019).Guardant Health, Inc., a precision oncology company, Director (since 2019). - Bahija Jallal自2018年2月起担任公司董事。Jallal女士自2019年1月起担任Immunocore Limited T细胞受体生物技术公司首席执行官。在此之前,她曾担任AstraZeneca PLC“ AstraZeneca”执行副总裁。 ”(制药和生物制药业务)和阿斯利康(AstraZeneca)的子公司MedImmune(生物技术业务)总裁,自2013年起。她于2006年加入MedImmune,并于2010年至2013年担任各种研发职位,包括研发执行副总裁。在加入AstraZeneca之前,Jallal曾在Chiron公司工作,担任副总裁,药物评估和开发。Bahija在巴黎第七大学获得生物学硕士学位,在巴黎第六大学皮埃尔和玛丽居里大学获得生理学博士学位。Jallal女士自2019年1月起担任Immunocore Limited董事,自2019年4月起担任Guardant Health,Inc。(精密肿瘤学公司)董事。她是约翰·霍普金斯大学董事会成员,也是约翰·霍普金斯大学董事会成员。马里兰州健康科学研究园公司。贾拉勒女士还曾于2016年至2018年担任科学界妇女协会的董事和前任主席。
- Bahija Jallal Immunocore Limited, a T-cell receptor biotechnology company, CEO since January 2019.AstraZeneca PLC ("AstraZeneca”), a pharmaceutical and biopharmaceutical business, Executive Vice President (2013-2019).MedImmune, a biotechnology business and a subsidiary of AstraZeneca, President (2013-2019), Executive Vice President, Research and Development (2010-2013) and various other research and development positions (2006-2010).Immunocore Limited, Director (since 2019).Guardant Health, Inc., a precision oncology company, Director (since 2019).
- Susan D. DeVore
-
Susan D. DeVorePremier, Inc.,一家医疗保健改进公司,从2003年到2021年6月担任各种职务,最近的职务是2019年至2021年5月的首席执行官和总裁(2013-2019年)。Premier 医疗保健解决方案公司(Premier, Inc.的子公司),总裁兼首席执行官(2009-2019年)和董事(2009-2021年5月)。AdventHealth,医疗保健系统,董事(自2020年起)。Cap Gemini/Ernst & Young LLP,一家管理咨询公司,从1988年到2002年担任各种职务,包括制造/高科技和媒体/娱乐部门的副总裁兼部门负责人(2001-2002年)和北美高增长中型市场部门的部门负责人(2000-2001年)。Unum Group,一家金融保护福利公司,董事(自2018年起),Premier,Inc.,主任(2013年至2021年5月)。
Susan D. DeVore Premier, Inc., a healthcare improvement company, various roles from 2003 until June 2021 with the most recent as CEO 2019-May 2021 and President (2013-2019).Premier Healthcare Solutions, Inc. (subsidiary of Premier, Inc.), President and CEO (2009-2019) and Director (2009-May 2021).AdventHealth, a healthcare system, Director (since 2020).Cap Gemini/Ernst & Young LLP, a management consulting company, various roles from 1988 until 2002 including VP and Sector Leader, Manufacturing/High Tech & Media/Entertainment Units (2001-2002) and Sector Leader, High Growth Middle Market Division, North America (2000-2001).Unum Group, a financial protection benefits company, Director (since 2018).Premier, Inc., Director (2013-May 2021). - Susan D. DeVorePremier, Inc.,一家医疗保健改进公司,从2003年到2021年6月担任各种职务,最近的职务是2019年至2021年5月的首席执行官和总裁(2013-2019年)。Premier 医疗保健解决方案公司(Premier, Inc.的子公司),总裁兼首席执行官(2009-2019年)和董事(2009-2021年5月)。AdventHealth,医疗保健系统,董事(自2020年起)。Cap Gemini/Ernst & Young LLP,一家管理咨询公司,从1988年到2002年担任各种职务,包括制造/高科技和媒体/娱乐部门的副总裁兼部门负责人(2001-2002年)和北美高增长中型市场部门的部门负责人(2000-2001年)。Unum Group,一家金融保护福利公司,董事(自2018年起),Premier,Inc.,主任(2013年至2021年5月)。
- Susan D. DeVore Premier, Inc., a healthcare improvement company, various roles from 2003 until June 2021 with the most recent as CEO 2019-May 2021 and President (2013-2019).Premier Healthcare Solutions, Inc. (subsidiary of Premier, Inc.), President and CEO (2009-2019) and Director (2009-May 2021).AdventHealth, a healthcare system, Director (since 2020).Cap Gemini/Ernst & Young LLP, a management consulting company, various roles from 1988 until 2002 including VP and Sector Leader, Manufacturing/High Tech & Media/Entertainment Units (2001-2002) and Sector Leader, High Growth Middle Market Division, North America (2000-2001).Unum Group, a financial protection benefits company, Director (since 2018).Premier, Inc., Director (2013-May 2021).
- Elizabeth E. Tallett
-
Elizabeth E. Tallett,2011年加入公司监事会,审计委员会和薪酬委员会。2002年她担任一家早期到中期阶段的制药,生物技术和医疗设备公司的管理公司,狩猎合伙有限责任公司的出资人。她的高级管理经验,包括transcell技术有限公司的总裁兼首席执行官,Centocor药品公司的总裁,Parke-Davis执行委员会的成员,华纳公司全球战略规划的总监。她毕业于英格兰诺丁汉大学并获得数学和经济学双学士学位的荣誉。她是Principal金融集团股份有限公司,WellPoint股份有限公司和Meredith股份有限公司董事会的成员。她目前是Principal的首席董事。在过去的五年里,她还是Varian股份有限公司,Immunicon股份有限公司,Varian半导体设备股份有限公司, Coventry医疗保健股份有限公司和美国IntegraMed股份有限公司的董事。她是新泽西生物技术委员会的创始成员,是宾夕法尼亚Solebury学校的受托人。
Elizabeth E. Tallett Independent consultant to healthcare companies 2015-present.Hunter Partners, LLC, a healthcare consulting company, principal (2002-2015).Transcell Technologies, Inc., a specialty pharmaceuticals company, President and CEO (1992-1996).Centocor Pharmaceuticals, a biotechnology company, President (1987-1992).Parke-Davis, a pharmaceuticals company, various roles including Member of the Executive Committee (1973-1987).Moderna, Inc., a biotechnology company, Director (since 2020).Qiagen, N.V., a molecular diagnostics and life sciences company, Supervisory Director (since 2011).Meredith Corporation, a media company, Director (2008-December 2021).Principal Financial Group, Inc., a financial services company, Director (1992-May 2021; as lead director from 2007-2019).Coventry Health Care, Inc., a health insurance company, Director (1998-2013 including serving as lead director). - Elizabeth E. Tallett,2011年加入公司监事会,审计委员会和薪酬委员会。2002年她担任一家早期到中期阶段的制药,生物技术和医疗设备公司的管理公司,狩猎合伙有限责任公司的出资人。她的高级管理经验,包括transcell技术有限公司的总裁兼首席执行官,Centocor药品公司的总裁,Parke-Davis执行委员会的成员,华纳公司全球战略规划的总监。她毕业于英格兰诺丁汉大学并获得数学和经济学双学士学位的荣誉。她是Principal金融集团股份有限公司,WellPoint股份有限公司和Meredith股份有限公司董事会的成员。她目前是Principal的首席董事。在过去的五年里,她还是Varian股份有限公司,Immunicon股份有限公司,Varian半导体设备股份有限公司, Coventry医疗保健股份有限公司和美国IntegraMed股份有限公司的董事。她是新泽西生物技术委员会的创始成员,是宾夕法尼亚Solebury学校的受托人。
- Elizabeth E. Tallett Independent consultant to healthcare companies 2015-present.Hunter Partners, LLC, a healthcare consulting company, principal (2002-2015).Transcell Technologies, Inc., a specialty pharmaceuticals company, President and CEO (1992-1996).Centocor Pharmaceuticals, a biotechnology company, President (1987-1992).Parke-Davis, a pharmaceuticals company, various roles including Member of the Executive Committee (1973-1987).Moderna, Inc., a biotechnology company, Director (since 2020).Qiagen, N.V., a molecular diagnostics and life sciences company, Supervisory Director (since 2011).Meredith Corporation, a media company, Director (2008-December 2021).Principal Financial Group, Inc., a financial services company, Director (1992-May 2021; as lead director from 2007-2019).Coventry Health Care, Inc., a health insurance company, Director (1998-2013 including serving as lead director).
- R. Kerry Clark
-
R. Kerry Clark,是卡地纳健康公司的退休了的主席兼行政总裁,这家公司是医疗保健行业的领导提供商。他于2006年4月加入卡地纳健康公司,担任总裁兼首席执行官,2007年11月出任主席,于2009年9月退休。在加入卡地纳健康之前,2002-2006年期间,他是宝洁家庭健康公司的副董事会主席及董事,该公司的消费产品在超过140个国家出售。他在1974年加入了宝洁,并在2002年出任董事会副主席之前,担任各种重要职务;他一直担任该职位,直到于2006年4月离开公司。他在2009年成为通用磨坊公司董事,于2012年成为安富利公司的董事同时也是豪斯资本合伙公司的合伙人兼董事,这是一家投资公司。
R. Kerry Clark Cardinal Health, Inc., a healthcare products and services company, Chairman and CEO 2007-2009 and President and CEO (2006-2007).The Procter & Gamble Company ("Procter & Gamble"), a consumer products company, various positions (1974-2006) including Vice Chairman, Global Health, Baby & Family Care (2004-2006) and Vice Chairman & President, Global Market Development (2002-2004).The Christ Hospital in Cincinnati, Ohio, Director (since 2009).General Mills, Inc., a consumer food products company, Director (since 2009).Textron, Inc., an aircraft, defense and industrial products company, Director (since 2003).Avnet, Inc., an industrial distributor of electronic components, enterprise computer and storage products, Director (2012-2019). - R. Kerry Clark,是卡地纳健康公司的退休了的主席兼行政总裁,这家公司是医疗保健行业的领导提供商。他于2006年4月加入卡地纳健康公司,担任总裁兼首席执行官,2007年11月出任主席,于2009年9月退休。在加入卡地纳健康之前,2002-2006年期间,他是宝洁家庭健康公司的副董事会主席及董事,该公司的消费产品在超过140个国家出售。他在1974年加入了宝洁,并在2002年出任董事会副主席之前,担任各种重要职务;他一直担任该职位,直到于2006年4月离开公司。他在2009年成为通用磨坊公司董事,于2012年成为安富利公司的董事同时也是豪斯资本合伙公司的合伙人兼董事,这是一家投资公司。
- R. Kerry Clark Cardinal Health, Inc., a healthcare products and services company, Chairman and CEO 2007-2009 and President and CEO (2006-2007).The Procter & Gamble Company ("Procter & Gamble"), a consumer products company, various positions (1974-2006) including Vice Chairman, Global Health, Baby & Family Care (2004-2006) and Vice Chairman & President, Global Market Development (2002-2004).The Christ Hospital in Cincinnati, Ohio, Director (since 2009).General Mills, Inc., a consumer food products company, Director (since 2009).Textron, Inc., an aircraft, defense and industrial products company, Director (since 2003).Avnet, Inc., an industrial distributor of electronic components, enterprise computer and storage products, Director (2012-2019).
- Lewis Hay, III
-
Lewis Hay, III,Hay先生目前作为私募股权投资公司Clayton, Dubilier & Rice, LLC,业务顾问。从2012年7月到2013年12月他退休,Hay先生担任NextEra Energy, Inc.,前身为 FPL Group, Inc.,执行主席,一个国家领先的电子相关服务公司和北美最大的可再生能源发电机。从2001年6月到2001年7月,他担任NextEra Energy首席执行官;从2002年1月至2012年7月,他担任主席;2001年6月到2006年12月担任总裁。从2002年1月至2008年7月,他还担任Florida Power & Light Company首席执行官。他于1999年加入NextEra Energy担任财务副总裁、和首席财务官并从2000年3月到12月的2001年12月担任NextEra Energy Resources, LLC(原FPL Energy, LLC)总裁。2003年10月31日以来,Hay先生是Capital One Financial Corporation董事,并且也是Capital One, National Association董事。2004年4月以来,他曾任职于薪酬委员会;2013年5月以来任职于风险委员会;2007年4月以来任职于治理和提名委员会。他还曾担任财务和信任监督委员会主席,从2005年4月到2013年5月董事会被解散。他也是Harris Corporation和WellPoint, Inc.的一名董事。Hay先生是Edison Electric Institute和美国股东拥有的电力公司以及核能研究所的前主席。从2011年2月到2013年2月,Hay先生还曾任职于总统奥巴马“总统”年代就业和竞争力委员会。
Lewis Hay, III Clayton, Dubilier & Rice, LLC, a private equity investment firm, operating advisor since 2014 NextEra Energy, Inc. ("NextEra Energy”), an electricity-related services and renewable energy generator company, Executive Chairman (2012-2013), CEO (2001-2012), Chairman (2002-2012) and President (2001-2006), Artera Services, LLC, a provider of integrated infrastructure services to natural gas and electric industries, Director (since 2018 including for its predecessor company, PowerTeam Services, LLC), L3Harris Technologies, Inc., a global aerospace and defense technology firm, Director (since 2019 and 2002-2019 for its predecessor company, Harris Corporation), Capital One Financial Corporation, a financial services company, Director (2003-2019), NextEra Energy, Director (2001-2013). - Lewis Hay, III,Hay先生目前作为私募股权投资公司Clayton, Dubilier & Rice, LLC,业务顾问。从2012年7月到2013年12月他退休,Hay先生担任NextEra Energy, Inc.,前身为 FPL Group, Inc.,执行主席,一个国家领先的电子相关服务公司和北美最大的可再生能源发电机。从2001年6月到2001年7月,他担任NextEra Energy首席执行官;从2002年1月至2012年7月,他担任主席;2001年6月到2006年12月担任总裁。从2002年1月至2008年7月,他还担任Florida Power & Light Company首席执行官。他于1999年加入NextEra Energy担任财务副总裁、和首席财务官并从2000年3月到12月的2001年12月担任NextEra Energy Resources, LLC(原FPL Energy, LLC)总裁。2003年10月31日以来,Hay先生是Capital One Financial Corporation董事,并且也是Capital One, National Association董事。2004年4月以来,他曾任职于薪酬委员会;2013年5月以来任职于风险委员会;2007年4月以来任职于治理和提名委员会。他还曾担任财务和信任监督委员会主席,从2005年4月到2013年5月董事会被解散。他也是Harris Corporation和WellPoint, Inc.的一名董事。Hay先生是Edison Electric Institute和美国股东拥有的电力公司以及核能研究所的前主席。从2011年2月到2013年2月,Hay先生还曾任职于总统奥巴马“总统”年代就业和竞争力委员会。
- Lewis Hay, III Clayton, Dubilier & Rice, LLC, a private equity investment firm, operating advisor since 2014 NextEra Energy, Inc. ("NextEra Energy”), an electricity-related services and renewable energy generator company, Executive Chairman (2012-2013), CEO (2001-2012), Chairman (2002-2012) and President (2001-2006), Artera Services, LLC, a provider of integrated infrastructure services to natural gas and electric industries, Director (since 2018 including for its predecessor company, PowerTeam Services, LLC), L3Harris Technologies, Inc., a global aerospace and defense technology firm, Director (since 2019 and 2002-2019 for its predecessor company, Harris Corporation), Capital One Financial Corporation, a financial services company, Director (2003-2019), NextEra Energy, Director (2001-2013).
- Ryan M. Schneider
-
Ryan M. Schneider,2001年12月,Schneider先生加入 Capital One。2001年12月至2007年12月,Schneider先生在Capital One担任多个职位,包括汽车金融执行副总裁和美国卡执行副总裁。2007年12月,Schneider先生成为信用卡总裁,在这个职位上,他负责所有Capital One顾客和商业小企业信用卡额度,包括在美国,英国和加拿大的企业。Schneider先生也担任Capital One Bank USA, National Association董事。
Ryan M. Schneider Realogy Holdings Corp. "Realogy”, a residential real estate services company, CEO and President (since December 2017), President and Chief Operating Officer (October 2017-December 2017).McKinsey & Company, an international consulting firm, Senior Advisor -2017 One Financial Corporation, a financial services company, various positions (2001-2017), including Senior Advisor (2016-2017) and President, Card Business (2007-2016).Capital One Bank (USA) N.A., Director (2007-2016).Realogy, Director (since 2017). - Ryan M. Schneider,2001年12月,Schneider先生加入 Capital One。2001年12月至2007年12月,Schneider先生在Capital One担任多个职位,包括汽车金融执行副总裁和美国卡执行副总裁。2007年12月,Schneider先生成为信用卡总裁,在这个职位上,他负责所有Capital One顾客和商业小企业信用卡额度,包括在美国,英国和加拿大的企业。Schneider先生也担任Capital One Bank USA, National Association董事。
- Ryan M. Schneider Realogy Holdings Corp. "Realogy”, a residential real estate services company, CEO and President (since December 2017), President and Chief Operating Officer (October 2017-December 2017).McKinsey & Company, an international consulting firm, Senior Advisor -2017 One Financial Corporation, a financial services company, various positions (2001-2017), including Senior Advisor (2016-2017) and President, Card Business (2007-2016).Capital One Bank (USA) N.A., Director (2007-2016).Realogy, Director (since 2017).
- Ramiro G. Peru
-
Ramiro G. Peru,他担任斯威夫特公司的执行副总裁兼首席财务官(从2007年6月到2007年12月),费尔普斯道奇公司的执行副总裁兼首席财务官(从2004年到2007年), 菲尔普斯道奇公司的高级副总裁兼首席财务官(从1999年到2004年)和WellPoint,公司的董事(自2004年以来)。
Ramiro G. Peru Swift Corporation, a transportation company, Executive Vice President and CFO June-December 2007 Phelps Dodge Corporation ("Phelps Dodge”), a mining and manufacturing company, various finance and accounting positions with Phelps Dodge and its affiliates (1979-2007) including Executive Vice President and CFO (1999-2007), UNS Energy Corporation ("UNS Energy"), an electric and gas utility holding company and a subsidiary of Fortis Inc., a utility holding company, Director (since 2007), Bluemedia, Inc., a large format printer, Director (since 2018), SM Energy Company, an oil and gas exploration and production company, Director (since 2014), UNS Energy (publicly traded until August 2014), Director (2007-2014), WellPoint Health Networks, Inc., Director (2003-2004). - Ramiro G. Peru,他担任斯威夫特公司的执行副总裁兼首席财务官(从2007年6月到2007年12月),费尔普斯道奇公司的执行副总裁兼首席财务官(从2004年到2007年), 菲尔普斯道奇公司的高级副总裁兼首席财务官(从1999年到2004年)和WellPoint,公司的董事(自2004年以来)。
- Ramiro G. Peru Swift Corporation, a transportation company, Executive Vice President and CFO June-December 2007 Phelps Dodge Corporation ("Phelps Dodge”), a mining and manufacturing company, various finance and accounting positions with Phelps Dodge and its affiliates (1979-2007) including Executive Vice President and CFO (1999-2007), UNS Energy Corporation ("UNS Energy"), an electric and gas utility holding company and a subsidiary of Fortis Inc., a utility holding company, Director (since 2007), Bluemedia, Inc., a large format printer, Director (since 2018), SM Energy Company, an oil and gas exploration and production company, Director (since 2014), UNS Energy (publicly traded until August 2014), Director (2007-2014), WellPoint Health Networks, Inc., Director (2003-2004).
- Robert L. Dixon, Jr.
-
Robert L. Dixon, Jr.,2011年7月以来,他一直担任公司的董事。他一直担任百事可乐公司的全球高级副总裁兼首席信息官(自2007年以来)。此前,他担任宝洁公司不同职位(自1977年以来),包括全球副总裁服务(从2005年到2007年)。他担任乔治亚理工学院的顾问委员会的主席(从2003年到2009年),目前是国际商业机器公司的顾问委员会成员。
Robert L. Dixon, Jr. RD Factor, Inc., a digital and information technology consulting business, owner since 2016 PepsiCo, Inc., a food and beverages company, Senior Vice President -2016 and Senior Vice President and Global Chief Information Officer (2007-2016), Procter & Gamble, various positions (1977-2007), including Vice President of Global Business Services (2005-2007), International Business Machines Corporation, a technology and consulting company, CIO Advisory Board (2011-2017), Georgia Institute of Technology, President's Advisory Board (since 2017), the College of Computing Advisory Board (since 2019) and Trustee of the Foundation (since 2017).Build-A-Bear Workshop, Inc., a specialty retailer, Director (since 2018).Okta, Inc., an identity management platform, Director (since 2019). - Robert L. Dixon, Jr.,2011年7月以来,他一直担任公司的董事。他一直担任百事可乐公司的全球高级副总裁兼首席信息官(自2007年以来)。此前,他担任宝洁公司不同职位(自1977年以来),包括全球副总裁服务(从2005年到2007年)。他担任乔治亚理工学院的顾问委员会的主席(从2003年到2009年),目前是国际商业机器公司的顾问委员会成员。
- Robert L. Dixon, Jr. RD Factor, Inc., a digital and information technology consulting business, owner since 2016 PepsiCo, Inc., a food and beverages company, Senior Vice President -2016 and Senior Vice President and Global Chief Information Officer (2007-2016), Procter & Gamble, various positions (1977-2007), including Vice President of Global Business Services (2005-2007), International Business Machines Corporation, a technology and consulting company, CIO Advisory Board (2011-2017), Georgia Institute of Technology, President's Advisory Board (since 2017), the College of Computing Advisory Board (since 2019) and Trustee of the Foundation (since 2017).Build-A-Bear Workshop, Inc., a specialty retailer, Director (since 2018).Okta, Inc., an identity management platform, Director (since 2019).
- Susan D. DeVore
-
Susan D. DeVore,2013年5月以来,她一直担任总裁兼首席执行官,以及Premier公司的董事会成员。她曾担任PHSI公司及其Premier公司的普通合伙人,也曾担任PHSI公司的董事会成员(2009年以来)。从2009年到2013年,她曾是Premier公司的管理委员会成员。她曾担任PHSI公司的首席营运官(从2006年到2009年),以及Premier公司的一些其它实体的首席运营官(从2007年到2009年)。她拥有执行经验,包括任职安永会计师事务所(Ernst & Young)20年以上,在那里她曾担任高级医疗行业管理实践的领导者。她也曾担任下列非盈利组织的董事会成员:Healthcare Leadership Council、American Diversified Reinsurance公司、Coalition to Protect America’s Healthcare、Medicare Rights Center、 Charlotte Chamber of Commerce 、the Institute of Medicine Roundtable on Value and Science Driven Healthcare。她也担任Adventist Health System的审计委员会和财务委员会的成员。她持有the University of North Carolina at Charlotte的学士学位,以及McGill University的管理硕士学位。
Susan D. DeVore has served as the Chief Executive Officer of Premier, Inc., a leading health care improvement company, since its initial public offering in 2013. She plans to step down as CEO and a director of Premier in May 2021 before retiring later in the year. She previously served as President of Premier from 2013 to April 2019 and before that served as President and Chief Executive Officer for its predecessor company, Premier Healthcare Solutions, Inc. She also previously served as the Chief Operating Officer for a number of affiliated Premier entities. Prior to joining Premier, Ms. DeVore had two decades of finance, strategy and health care consulting experience. She also qualifies as an audit committee financial expert under SEC regulations. - Susan D. DeVore,2013年5月以来,她一直担任总裁兼首席执行官,以及Premier公司的董事会成员。她曾担任PHSI公司及其Premier公司的普通合伙人,也曾担任PHSI公司的董事会成员(2009年以来)。从2009年到2013年,她曾是Premier公司的管理委员会成员。她曾担任PHSI公司的首席营运官(从2006年到2009年),以及Premier公司的一些其它实体的首席运营官(从2007年到2009年)。她拥有执行经验,包括任职安永会计师事务所(Ernst & Young)20年以上,在那里她曾担任高级医疗行业管理实践的领导者。她也曾担任下列非盈利组织的董事会成员:Healthcare Leadership Council、American Diversified Reinsurance公司、Coalition to Protect America’s Healthcare、Medicare Rights Center、 Charlotte Chamber of Commerce 、the Institute of Medicine Roundtable on Value and Science Driven Healthcare。她也担任Adventist Health System的审计委员会和财务委员会的成员。她持有the University of North Carolina at Charlotte的学士学位,以及McGill University的管理硕士学位。
- Susan D. DeVore has served as the Chief Executive Officer of Premier, Inc., a leading health care improvement company, since its initial public offering in 2013. She plans to step down as CEO and a director of Premier in May 2021 before retiring later in the year. She previously served as President of Premier from 2013 to April 2019 and before that served as President and Chief Executive Officer for its predecessor company, Premier Healthcare Solutions, Inc. She also previously served as the Chief Operating Officer for a number of affiliated Premier entities. Prior to joining Premier, Ms. DeVore had two decades of finance, strategy and health care consulting experience. She also qualifies as an audit committee financial expert under SEC regulations.
高管简历
中英对照 |  中文 |  英文- Gail K. Boudreaux
Gail K. Boudreaux,自2011年1月担任联合健康集团的首席执行官;自2008年5月起担任联合健康集团的执行副总裁;从2005年至2008年,她担任医疗保健服务公司“HCSC”的外部运营执行副总裁;此前担任伊利诺伊州蓝十字公司和蓝盾公司的总裁,医疗保健服务公司的一个部门。加入HCSC前,包德留克斯女士在安泰公司担任多个职位,包括安泰保险集团高级副总裁。包德留克斯女士获得了哥伦比亚商学院的工商管理硕士学位和达特茅斯学院的心理学学士学位。她担任埃克西尔能源公司的董事,此前担任健赞公司的董事。
Gail K. Boudreaux has served as the President & Chief Executive Officer of Anthem, Inc., a leading health benefits provider, since November 2017. From July 2015 to November 2017 Ms. Boudreaux served as Chief Executive Officer of GKB Global Health, LLC, a healthcare consulting company. She previously held executive level leadership positions at UnitedHealth Group, Inc. and its subsidiary, UnitedHealthcare, and at Health Care Services Corporation and Aetna, Inc..Anthem, Inc.,Zimmer Biomet Holdings, Inc.,Xcel Energy Inc.,Novavax, Inc..- Gail K. Boudreaux,自2011年1月担任联合健康集团的首席执行官;自2008年5月起担任联合健康集团的执行副总裁;从2005年至2008年,她担任医疗保健服务公司“HCSC”的外部运营执行副总裁;此前担任伊利诺伊州蓝十字公司和蓝盾公司的总裁,医疗保健服务公司的一个部门。加入HCSC前,包德留克斯女士在安泰公司担任多个职位,包括安泰保险集团高级副总裁。包德留克斯女士获得了哥伦比亚商学院的工商管理硕士学位和达特茅斯学院的心理学学士学位。她担任埃克西尔能源公司的董事,此前担任健赞公司的董事。
- Gail K. Boudreaux has served as the President & Chief Executive Officer of Anthem, Inc., a leading health benefits provider, since November 2017. From July 2015 to November 2017 Ms. Boudreaux served as Chief Executive Officer of GKB Global Health, LLC, a healthcare consulting company. She previously held executive level leadership positions at UnitedHealth Group, Inc. and its subsidiary, UnitedHealthcare, and at Health Care Services Corporation and Aetna, Inc..Anthem, Inc.,Zimmer Biomet Holdings, Inc.,Xcel Energy Inc.,Novavax, Inc..
- Peter D. Haytaian
Peter D. Haytaian自2014年起担任公司执行副总裁和政府业务部总裁。2012年,Haytaian先生加盟本公司,收购Amerigroup公司(Amerigroup)和最近担任我们的医疗业务总裁。2005年至2013年,Haytaian先生在Amerigroup担任几个领导职务,包括担任北地区医疗业务的首席执行官和Amerigroup Medicare Advantage企业的主管。
Peter D. Haytaian has served as our Executive Vice President and President of our Diversified Business Group and IngenioRx since October 2021. Prior to his current role, Mr. Haytaian served as Executive Vice President and President of our Commercial and Specialty Business Division beginning in April 2018. From June 2014 until April 2018 Mr. Haytaian served as our Executive Vice President and President of the Government Business Division. Mr. Haytaian joined the Company in 2012 with our acquisition of Amerigroup Corporation “Amerigroup” and served as President of our Medicaid business from 2013 until 2014. From 2005 to 2013 Mr. Haytaian held several leadership positions with Amerigroup, including serving as Chief Executive Officer of the North Region for Amerigroup's Medicaid business from 2012 until 2013. Mr. Haytaian has extensive experience leading Medicare and Medicaid programs with Amerigroup and, prior thereto, with Oxford Health Plans, Inc.- Peter D. Haytaian自2014年起担任公司执行副总裁和政府业务部总裁。2012年,Haytaian先生加盟本公司,收购Amerigroup公司(Amerigroup)和最近担任我们的医疗业务总裁。2005年至2013年,Haytaian先生在Amerigroup担任几个领导职务,包括担任北地区医疗业务的首席执行官和Amerigroup Medicare Advantage企业的主管。
- Peter D. Haytaian has served as our Executive Vice President and President of our Diversified Business Group and IngenioRx since October 2021. Prior to his current role, Mr. Haytaian served as Executive Vice President and President of our Commercial and Specialty Business Division beginning in April 2018. From June 2014 until April 2018 Mr. Haytaian served as our Executive Vice President and President of the Government Business Division. Mr. Haytaian joined the Company in 2012 with our acquisition of Amerigroup Corporation “Amerigroup” and served as President of our Medicaid business from 2013 until 2014. From 2005 to 2013 Mr. Haytaian held several leadership positions with Amerigroup, including serving as Chief Executive Officer of the North Region for Amerigroup's Medicaid business from 2012 until 2013. Mr. Haytaian has extensive experience leading Medicare and Medicaid programs with Amerigroup and, prior thereto, with Oxford Health Plans, Inc.
- Ronald W. Penczek
Ronald W. Penczek自2015年11月起担任我们的高级副总裁和主管,并自2015年12月起担任我们的首席会计官。2013年8月至2015年11月,他担任我们的副总裁兼主管。在任命之前, 2008年1月至2013年8月Penczek先生担任副总裁和助理总监,并于2006年2月至2008年1月担任财务部门的其他职务。在加入我们之前,Penczek先生于2000年至2005年担任CNA Insurance的职员副总裁, 1992年至2000年担任PricewaterhouseCoopers LLP的经理。
Ronald W. Penczek has served as our Controller since November 2015 and as our Chief Accounting Officer since December 2015. He served as our Vice President and Controller from 2013 to 2015. Prior to that appointment, Mr. Penczek served as Vice President and Assistant Controller from 2008 to 2013 and in various other roles in our finance department from 2006 until 2008. Before joining us in 2005 Mr. Penczek was a Staff Vice President with CNA Insurance from 2000 to 2005 and had various positions with PricewaterhouseCoopers LLP from 1992 to 2000 including as a Manager.- Ronald W. Penczek自2015年11月起担任我们的高级副总裁和主管,并自2015年12月起担任我们的首席会计官。2013年8月至2015年11月,他担任我们的副总裁兼主管。在任命之前, 2008年1月至2013年8月Penczek先生担任副总裁和助理总监,并于2006年2月至2008年1月担任财务部门的其他职务。在加入我们之前,Penczek先生于2000年至2005年担任CNA Insurance的职员副总裁, 1992年至2000年担任PricewaterhouseCoopers LLP的经理。
- Ronald W. Penczek has served as our Controller since November 2015 and as our Chief Accounting Officer since December 2015. He served as our Vice President and Controller from 2013 to 2015. Prior to that appointment, Mr. Penczek served as Vice President and Assistant Controller from 2008 to 2013 and in various other roles in our finance department from 2006 until 2008. Before joining us in 2005 Mr. Penczek was a Staff Vice President with CNA Insurance from 2000 to 2005 and had various positions with PricewaterhouseCoopers LLP from 1992 to 2000 including as a Manager.
- Felicia F. Norwood
Felicia F. Norwood自2018年6月起担任我们的执行副总裁兼政府业务部总裁。在加入我们之前,她于2015年1月至2018年6月担任伊利诺伊州医疗保健和家庭服务部主任。 在任命之前,Norwood女士从2010年1月至2013年5月担任Aetna,Inc。健康保险的中美洲地区总裁。
Felicia F. Norwood has served as our Executive Vice President and President of the Government Business Division since June 2018. Prior to joining us, she was Director of The Department of Healthcare and Family Services for the State of Illinois from 2015 to June 2018. Prior to that appointment, Ms. Norwood served as President of the Mid-America Region for Aetna from 2010 until 2013.- Felicia F. Norwood自2018年6月起担任我们的执行副总裁兼政府业务部总裁。在加入我们之前,她于2015年1月至2018年6月担任伊利诺伊州医疗保健和家庭服务部主任。 在任命之前,Norwood女士从2010年1月至2013年5月担任Aetna,Inc。健康保险的中美洲地区总裁。
- Felicia F. Norwood has served as our Executive Vice President and President of the Government Business Division since June 2018. Prior to joining us, she was Director of The Department of Healthcare and Family Services for the State of Illinois from 2015 to June 2018. Prior to that appointment, Ms. Norwood served as President of the Mid-America Region for Aetna from 2010 until 2013.
- Charles M. Kendrick, Jr.
Charles M. Kendrick, Jr.担任执行副总裁兼总裁,Anthem, Inc.的商业和专业业务部门自2021年10月。从2021年1月到2021年10月,Kendrick先生担任商业市场西方市场主席,加利福尼亚、科罗拉多、印第安娜、肯塔基、密苏里、内华达州、俄亥俄和威斯康星。Kendrick先生于1995加入Anthem, Inc.,并在整个组织中担任了许多领导角色,包括担任总统、国歌、中央市场2015至2021年1月,以及2010至2015年间格鲁吉亚国歌和蓝盾国歌的总经理和总经理。
Charles M. Kendrick, Jr. has served as Executive Vice President and President of our Commercial and Specialty Business Division since October 2021. From January 2021 until October 2021 Mr. Kendrick served as President of our Commercial Business West Markets California, Colorado, Indiana, Kentucky, Missouri, Nevada, Ohio and Wisconsin. Mr. Kendrick joined us in 1995 and has held numerous leadership roles across the organization, including serving as President, Anthem National Accounts/Central Markets from 2015 until January 2021 and President of National Accounts and General Manager for Anthem Blue Cross and Blue Shield of Georgia from 2010 until 2015.- Charles M. Kendrick, Jr.担任执行副总裁兼总裁,Anthem, Inc.的商业和专业业务部门自2021年10月。从2021年1月到2021年10月,Kendrick先生担任商业市场西方市场主席,加利福尼亚、科罗拉多、印第安娜、肯塔基、密苏里、内华达州、俄亥俄和威斯康星。Kendrick先生于1995加入Anthem, Inc.,并在整个组织中担任了许多领导角色,包括担任总统、国歌、中央市场2015至2021年1月,以及2010至2015年间格鲁吉亚国歌和蓝盾国歌的总经理和总经理。
- Charles M. Kendrick, Jr. has served as Executive Vice President and President of our Commercial and Specialty Business Division since October 2021. From January 2021 until October 2021 Mr. Kendrick served as President of our Commercial Business West Markets California, Colorado, Indiana, Kentucky, Missouri, Nevada, Ohio and Wisconsin. Mr. Kendrick joined us in 1995 and has held numerous leadership roles across the organization, including serving as President, Anthem National Accounts/Central Markets from 2015 until January 2021 and President of National Accounts and General Manager for Anthem Blue Cross and Blue Shield of Georgia from 2010 until 2015.
- Blair W. Todt
Blair W. Todt,2010年4月加入WellCare,现任本公司的高级副总裁、首席战略与发展官。2010年4月至2013年11月,他是本公司的高级副总裁、首席合规官。加入WellCare之前,2007年2月至2010年3月,他担任MedCath Corporation的高级副总裁、法律总顾问、秘书,这是一个健康护理提供商;2005年5月至2007年2月,他在BearingPoint, Inc. (原KPMG Consulting Inc)担任合规与诉讼副法律总顾问。他在The George Washington University获得学士学位,在Brooklyn Law School获得法律博士学位。
Blair W. Todt has served as our Executive Vice President and Chief Legal Officer since November 2020 and our interim head of human resources and global security and safety team since January 2022. Prior to joining us, Mr. Todt served as Senior Vice President, Legal, Compliance & Business Performance and Chief Legal Officer of HCSC from 2016 to July 2020. Prior to joining HCSC, Mr. Todt held a variety of leadership roles at WellCare Health Plans, Inc. health insurance company, with his most recent role as Senior Vice President, Chief Legal and Administrative Officer and Secretary from 2010 until 2016.- Blair W. Todt,2010年4月加入WellCare,现任本公司的高级副总裁、首席战略与发展官。2010年4月至2013年11月,他是本公司的高级副总裁、首席合规官。加入WellCare之前,2007年2月至2010年3月,他担任MedCath Corporation的高级副总裁、法律总顾问、秘书,这是一个健康护理提供商;2005年5月至2007年2月,他在BearingPoint, Inc. (原KPMG Consulting Inc)担任合规与诉讼副法律总顾问。他在The George Washington University获得学士学位,在Brooklyn Law School获得法律博士学位。
- Blair W. Todt has served as our Executive Vice President and Chief Legal Officer since November 2020 and our interim head of human resources and global security and safety team since January 2022. Prior to joining us, Mr. Todt served as Senior Vice President, Legal, Compliance & Business Performance and Chief Legal Officer of HCSC from 2016 to July 2020. Prior to joining HCSC, Mr. Todt held a variety of leadership roles at WellCare Health Plans, Inc. health insurance company, with his most recent role as Senior Vice President, Chief Legal and Administrative Officer and Secretary from 2010 until 2016.
- John E. Gallina
John E. Gallina ,他曾担任高级副总裁、财务总监、首席财务官和首席风险官(自2011年5月以来)。自1994年以来,他担任美国众多的财务职务。以前,他担任负责内部审计和持续改进的高级副总裁(2010年3月以来)、高级财务副总裁(2008年8月以来)和临时首席财务官(从2008年4月到2008年9月)。同时,他曾担任全面健康解决方案业务单位的首席财务官(从2008年1月到2010年1月)。之前,他担任副总裁,负责企业财务计划和分析(从2000年11月到2008年1月)。
John E. Gallina has served as our Executive Vice President and Chief Financial Officer since 2016. Mr. Gallina joined Anthem in 1994 and has held a variety of leadership roles across the organization. Prior to his current role, Mr. Gallina served as Anthem's Chief Financial Officer for the Commercial and Specialty Business Division from 2015 to 2016 and as Senior Vice President and Chief Accounting Officer from 2013 to 2015. Other leadership positions held during his tenure include Senior Vice President, Chief Accounting Officer and Chief Risk Officer from 2011 to 2013 while also holding the title of Controller from 2011 to 2013. Before joining the Company, Mr. Gallina spent 12 years with Coopers & Lybrand in various positions, including as an Audit Senior Manager.- John E. Gallina ,他曾担任高级副总裁、财务总监、首席财务官和首席风险官(自2011年5月以来)。自1994年以来,他担任美国众多的财务职务。以前,他担任负责内部审计和持续改进的高级副总裁(2010年3月以来)、高级财务副总裁(2008年8月以来)和临时首席财务官(从2008年4月到2008年9月)。同时,他曾担任全面健康解决方案业务单位的首席财务官(从2008年1月到2010年1月)。之前,他担任副总裁,负责企业财务计划和分析(从2000年11月到2008年1月)。
- John E. Gallina has served as our Executive Vice President and Chief Financial Officer since 2016. Mr. Gallina joined Anthem in 1994 and has held a variety of leadership roles across the organization. Prior to his current role, Mr. Gallina served as Anthem's Chief Financial Officer for the Commercial and Specialty Business Division from 2015 to 2016 and as Senior Vice President and Chief Accounting Officer from 2013 to 2015. Other leadership positions held during his tenure include Senior Vice President, Chief Accounting Officer and Chief Risk Officer from 2011 to 2013 while also holding the title of Controller from 2011 to 2013. Before joining the Company, Mr. Gallina spent 12 years with Coopers & Lybrand in various positions, including as an Audit Senior Manager.
- Gloria M. McCarthy
Gloria M. McCarthy ,她曾担任我们的执行副总裁,负责企业执行和效率(2012年10月以来)。之前,她担任执行副总裁,负责首席执行官办公室(2012年2月以来),负责卓越运营的高级副总裁(2008年6月以来),负责运营服务的高级副总裁(从2006年12月到2008年6月), 东部区域高级副总裁兼首席运营官(从2005年12月到2005年12月)。我们在2005年12月收购WellChoice之前,她担任WellChoice的执行副总裁兼首席运营官。
Gloria M. McCarthy has served as our Executive Vice President and Chief Administrative Officer since 2013. She was Executive Vice President of Enterprise Execution and Efficiency from 2012 to 2013. Prior to that appointment, she served as Senior Vice President for Operational Excellence from 2008 to 2012 as Senior Vice President of Service Operations from 2006 to 2008 and as Senior Vice President and Chief Operating Officer of our East Region from 2005 to 2006. Prior to our acquisition of WellChoice, Inc. “WellChoice” in 2005 Ms. McCarthy served as Executive Vice President and Chief Operating Officer of WellChoice.- Gloria M. McCarthy ,她曾担任我们的执行副总裁,负责企业执行和效率(2012年10月以来)。之前,她担任执行副总裁,负责首席执行官办公室(2012年2月以来),负责卓越运营的高级副总裁(2008年6月以来),负责运营服务的高级副总裁(从2006年12月到2008年6月), 东部区域高级副总裁兼首席运营官(从2005年12月到2005年12月)。我们在2005年12月收购WellChoice之前,她担任WellChoice的执行副总裁兼首席运营官。
- Gloria M. McCarthy has served as our Executive Vice President and Chief Administrative Officer since 2013. She was Executive Vice President of Enterprise Execution and Efficiency from 2012 to 2013. Prior to that appointment, she served as Senior Vice President for Operational Excellence from 2008 to 2012 as Senior Vice President of Service Operations from 2006 to 2008 and as Senior Vice President and Chief Operating Officer of our East Region from 2005 to 2006. Prior to our acquisition of WellChoice, Inc. “WellChoice” in 2005 Ms. McCarthy served as Executive Vice President and Chief Operating Officer of WellChoice.